NCT00371904View on ClinicalTrials.gov

Trial of Rituximab Given Pre-Transplant to Sensitised Live Donor Kidney Recipients

PHASE2UnknownINTERVENTIONAL
Enrollment

192

Participants

Timeline

Start Date

April 30, 2006

Study Completion Date

January 31, 2009

Conditions
Kidney Transplantation
Interventions
DRUG

Rituximab

Single dose (375 mg/m2) of rituximab to be given intravenously (IV) 14 days prior to transplantation

DRUG

Standard Care

Standard care

Trial Locations (3)

2305

RECRUITING

Newcastle Transplant Unit, John Hunter Hospital, Newcastle

3052

NOT_YET_RECRUITING

Royal Melbourne Hospital, Parkville

3168

NOT_YET_RECRUITING

Monash Medical Centre, Clayton

Sponsors
All Listed Sponsors
collaborator

Melbourne Health

OTHER

collaborator

Princess Alexandra Hospital, Brisbane, Australia

OTHER

collaborator

Royal Prince Alfred Hospital, Sydney, Australia

OTHER

collaborator

Auckland City Hospital

OTHER_GOV

collaborator

Monash Medical Centre

OTHER

collaborator

Royal Perth Hospital

OTHER

collaborator

Westmead Hospital

UNKNOWN

collaborator

Royal Adelaide Hospital

OTHER

lead

Hunter and New England Health

OTHER